Napravi najbolje investicije svog života.
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Od 2 evra osigurajте
Analiza akcija
Profil

Boston Scientific Akcija

BSX
US1011371077
884113

Cena

73,76
Danas +/-
+0,73
Danas %
+1,09 %
P

Boston Scientific Cena akcije

%
Nedeljno
Detalji

Kurs

ⓘ

Pregled

Dijagram kursa akcija pruža detaljne i dinamičke uvide u performanse Boston Scientific-akcije i prikazuje dnevno, nedeljno ili mesečno agregirane kurseve. Korisnici mogu prelaziti između različitih vremenskih okvira kako bi pažljivo analizirali istoriju akcije i doneli informisane investicione odluke.

Intraday funkcija

Intraday funkcija pruža podatke u realnom vremenu i omogućava investitorima da posmatraju fluktuacije kursa Boston Scientific-akcije tokom trgovačkog dana kako bi doneli pravovremene i strateške investicione odluke.

Ukupan prinos i relativna promena cene

Pogledajte ukupan prinos Boston Scientific-akcije kako biste ocenili njenu rentabilnost tokom vremena. Relativna promena cene, bazirana na prvoj dostupnoj ceni u izabranom vremenskom okviru, pruža uvide u performanse akcije i pomaže u ocenjivanju njenog investicionog potencijala.

Interpretacija i investiranje

Iskoristite opsežne podatke predstavljene u dijagramu kursa akcija da analizirate tržišne trendove, kretanje cena i potencijalne prinose od Boston Scientific. Donosite informisane investicione odluke upoređujući različite vremenske okvire i procenjujući Intraday podatke za optimizovano upravljanje portfoliom.

Boston Scientific Istorija kursa

DatumBoston Scientific Cena akcije
6. 8. 2024.73,76 undefined
5. 8. 2024.72,96 undefined
2. 8. 2024.74,50 undefined
1. 8. 2024.75,16 undefined
31. 7. 2024.73,88 undefined
30. 7. 2024.74,03 undefined
29. 7. 2024.75,59 undefined
26. 7. 2024.74,92 undefined
25. 7. 2024.74,26 undefined
24. 7. 2024.77,76 undefined
23. 7. 2024.78,59 undefined
22. 7. 2024.78,27 undefined
19. 7. 2024.77,56 undefined
18. 7. 2024.75,55 undefined
17. 7. 2024.77,41 undefined
16. 7. 2024.78,14 undefined
15. 7. 2024.78,02 undefined
12. 7. 2024.77,69 undefined
11. 7. 2024.76,89 undefined
10. 7. 2024.77,11 undefined
9. 7. 2024.76,51 undefined
8. 7. 2024.76,11 undefined

Boston Scientific Akcija Promet, EBIT, Dobit

  • 3 godine

  • 5 godina

  • 10 godina

  • 25 godina

  • Maks

Promet
EBIT
Profit
Detalji

Promet, Profit & EBIT

ⓘ

Razumevanje prometa, EBIT-a i prihoda

Dobijte uvid u Boston Scientific, sveobuhvatan pregled finansijskih performansi može se dobiti analizom dijagrama prometa, EBIT-a i prihoda. Promet predstavlja ukupni prihod koji Boston Scientific ostvaruje iz svojih glavnih poslova i pokazuje sposobnost kompanije da privlači i zadržava klijente. EBIT (Earnings Before Interest and Taxes) pruža informacije o operativnoj profitabilnosti kompanije, oslobođen od poreskih i kamatnih troškova. Deo prihoda odražava neto profit Boston Scientific, krajnju meru njegovog finansijskog zdravlja i profitabilnosti.

Godišnja analiza i poređenja

Pogledajte godišnje stubove kako biste razumeli godišnje performanse i rast Boston Scientific. Uporedite promet, EBIT i prihod kako biste procenili efikasnost i profitabilnost kompanije. Veći EBIT u poređenju s prošlom godinom ukazuje na unapređenje operativne efikasnosti. Slično tome, povećanje prihoda ukazuje na povećanu ukupnu profitabilnost. Analiza poređenja iz godine u godinu pomaže investitorima da razumeju rast i operativnu efikasnost kompanije.

Koristite očekivanja za investiranje

Predviđene vrednosti za naredne godine pružaju investitorima uvid u očekivane finansijske performanse Boston Scientific. Analiza ovih prognoza zajedno s istorijskim podacima pomaže da se donesu informisane investicione odluke. Investitori mogu proceniti potencijalne rizike i prinose i uskladiti svoje investicione strategije kako bi optimizovali profitabilnost i smanjili rizike.

Uvid u investicije

Upoređivanje prometa i EBIT-a pomaže u proceni operativne efikasnosti Boston Scientific, dok upoređivanje prometa i prihoda otkriva neto profitabilnost nakon uzimanja u obzir svih troškova. Investitori mogu steći dragocene uvide analizirajući ove finansijske parametre pažljivo i tako postaviti temelj za strateške investicione odluke kako bi iskoristili potencijal za rast Boston Scientific.

Boston Scientific Prihod, dobit i EBIT istorija

DatumBoston Scientific PrometBoston Scientific EBITBoston Scientific Profit
2029e25,14 milijardi undefined0 undefined0 undefined
2028e22,80 milijardi undefined6,64 milijardi undefined5,52 milijardi undefined
2027e20,98 milijardi undefined5,99 milijardi undefined4,92 milijardi undefined
2026e19,95 milijardi undefined5,52 milijardi undefined4,55 milijardi undefined
2025e18,16 milijardi undefined4,95 milijardi undefined4,04 milijardi undefined
2024e16,40 milijardi undefined4,38 milijardi undefined3,56 milijardi undefined
202314,24 milijardi undefined2,43 milijardi undefined1,57 milijardi undefined
202212,68 milijardi undefined2,07 milijardi undefined642,00 mil. undefined
202111,89 milijardi undefined2,11 milijardi undefined985,00 mil. undefined
20209,91 milijardi undefined902,00 mil. undefined-115,00 mil. undefined
201910,74 milijardi undefined1,82 milijardi undefined4,70 milijardi undefined
20189,82 milijardi undefined1,74 milijardi undefined1,67 milijardi undefined
20179,05 milijardi undefined1,67 milijardi undefined104,00 mil. undefined
20168,39 milijardi undefined1,34 milijardi undefined347,00 mil. undefined
20157,48 milijardi undefined924,00 mil. undefined-239,00 mil. undefined
20147,38 milijardi undefined1,04 milijardi undefined-119,00 mil. undefined
20137,14 milijardi undefined903,00 mil. undefined-121,00 mil. undefined
20127,25 milijardi undefined961,00 mil. undefined-4,07 milijardi undefined
20117,62 milijardi undefined1,02 milijardi undefined441,00 mil. undefined
20107,81 milijardi undefined993,00 mil. undefined-1,07 milijardi undefined
20098,19 milijardi undefined1,25 milijardi undefined-1,03 milijardi undefined
20088,05 milijardi undefined1,27 milijardi undefined-2,04 milijardi undefined
20078,36 milijardi undefined1,19 milijardi undefined-495,00 mil. undefined
20067,82 milijardi undefined1,23 milijardi undefined-3,58 milijardi undefined
20056,28 milijardi undefined2,02 milijardi undefined628,00 mil. undefined
20045,62 milijardi undefined1,71 milijardi undefined1,06 milijardi undefined

Boston Scientific Akcija Kennzahlen

  • Jednostavno

  • Prošireno

  • GuV

  • Bilans

  • Keš flou

 
PRIHOD (milijardi)RAST PRIHODA (%)BRUTO MARGINA (%)BRUTO PRIHOD (milijardi)EBIT (milijardi)EBIT-MARGA (%)NETO DOBITAK (milijardi)Rast dobiti (%)BROJ AKCIJA (milijardi)DOKUMENTA
198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e
0,120,160,230,320,730,891,191,551,832,232,842,662,672,923,485,626,287,828,368,058,197,817,627,257,147,387,488,399,059,8210,749,9111,8912,6814,2416,4018,1619,9520,9822,8025,14
-37,0744,6536,96132,7021,2833,9730,2318,0522,0127,22-6,260,349,2019,0861,8011,7224,486,85-3,671,71-4,67-2,36-4,89-1,463,321,3112,167,898,579,28-7,6619,926,6812,2915,1910,749,855,128,6810,26
56,0361,6464,3563,1766,0365,5869,0271,3168,9865,6763,6967,3864,3168,9670,8073,5674,3368,8369,5666,8166,2164,3463,2565,6067,6068,8870,4270,5671,0971,1370,6765,2469,0469,0069,65------
0,070,100,150,200,480,580,821,111,261,471,811,801,722,012,464,144,675,385,815,385,425,024,824,764,835,085,275,926,436,997,596,478,218,759,92000000
0,010,040,070,090,190,210,320,460,400,460,680,640,380,600,751,712,021,231,191,271,250,991,020,960,901,040,921,341,671,741,820,902,112,072,434,384,955,525,996,640
12,0725,1630,4329,5225,6523,2827,2029,3421,8520,5923,8923,9514,2920,4221,5530,4832,2115,6814,2815,7915,3212,7213,3313,2612,6414,0212,3615,9818,4517,7016,969,1017,7716,3317,0526,7127,2427,6628,5729,12-
0,010,020,040,060,120,14-0,020,170,11-0,260,370,37-0,050,370,471,060,63-3,58-0,50-2,04-1,03-1,070,44-4,07-0,12-0,12-0,240,350,101,674,70-0,120,990,641,573,564,044,554,925,520
-300,0075,0035,71112,2811,57-113,33-1.027,78-34,13-340,00-240,530,54-114,48-790,7426,54125,00-40,87-669,59-86,16311,31-49,663,90-141,41-1.022,45-97,03-1,65100,84-245,19-70,031.506,73181,27-102,45-956,52-34,82144,55126,8813,3612,638,2012,23-
0,380,380,380,400,680,700,760,800,800,780,820,820,800,830,850,860,841,271,491,501,511,521,521,411,341,321,341,381,391,401,411,421,431,441,46000000
-----------------------------------------
Detalji

GuV

ⓘ

Prihod i rast

Prihod Boston Scientific i rast prihoda su ključni za razumevanje finansijskog zdravlja i operativne efikasnosti kompanije. Konstantan rast prihoda ukazuje na sposobnost kompanije da efektivno tržišno plasira i prodaje svoje proizvode ili usluge, dok procentualni rast prihoda pokazuje brzinu rasta kompanije tokom godina.

Bruto marža

Bruto marža je ključni faktor koji pokazuje procenat prihoda iznad proizvodnih troškova. Viša bruto marža ukazuje na efikasnost kompanije u kontroli proizvodnih troškova i obećava potencijalnu profitabilnost I finansijsku stabilnost.

EBIT i EBIT marža

EBIT (Earnings Before Interest and Taxes) i EBIT marža pružaju duboke uvide u profitabilnost kompanije, bez uticaja kamata i poreza. Investitori često procenjuju ove metrike kako bi ocenili operativnu efikasnost i inherentnu profitabilnost kompanije nezavisno od njene finansijske strukture i poreskog okruženja.

Prihod i rast

Neto prihod i njegov kasniji rast su neophodni investitorima koji žele da razumeju profitabilnost kompanije. Konstantan rast prihoda naglašava sposobnost kompanije da povećava svoju profitabilnost tokom vremena i odražava operativnu efikasnost, stratešku konkurentnost i finansijsko zdravlje.

Izdate akcije

Izdate akcije se odnose na ukupan broj akcija koje je kompanija izdala. Ovo je ključno za izračunavanje bitnih pokazatelja kao što je zarada po akciji (EPS), koji je za investitore od kritične važnosti da procene profitabilnost kompanije po osnovu po akciji i pruža detaljniji pregled finansijskog zdravlja i vrednovanja.

Interpretacija godišnje usporedbe

Usporedba godišnjih podataka omogućuje investitorima da identifikuju trendove, procene rast kompanije i predviđaju potencijalne buduće performanse. Analiza kako se pokazatelji kao što su prihod, dohodak i marže menjaju iz godine u godinu može pružiti dragocene uvide u operativnu efikasnost, konkurentnost i finansijsko zdravlje kompanije.

Očekivanja i prognoze

Investitori često upoređuju trenutne i prošle finansijske podatke sa tržišnim očekivanjima. Ovaj uporedni pregled pomaže u ocenjivanju da li kompanija Boston Scientific postiže rezultate u skladu sa očekivanjima, ispod ili iznad proseka i pruža ključne podatke za odluke o investiranju.

 
AKTIVAREZERVNI NOVČANI FOND (milijardi)POTRAŽIVANJA (milijardi)S. POTRAŽIVANJA (mil.)ZAALIHE (milijardi)О. ТЕКУЋА ИМОВИНА (milijardi)ОБРТНА СРЕДСТВА (milijardi)MATERIJALNA IMOVINA (milijardi)DUGOR. INVEST. (mil.)LANGF. FORDER. (mil.)IMAT. IMOVINSKI RAČ. (milijardi)GOODWILL (milijardi)S. ULAGANJA. (milijardi)OSNOVNA SREDSTVA (milijardi)UKUPNA IMOVINA (milijardi)PASIVAOBIČNE AKCIJE (mil.)KAPITALNE REZERVE (milijardi)REZERVISANI DOBITAK (milijardi)S. SOPSTVENI KAP. (mil.)N. REAL. KURSG./-V. (mil.)KAPITAL VLASTI (milijardi)OBAVEZE (mil.)REZERVACIJA (milijardi)Kratkoročne obaveze (milijardi)KRATKOROČNI DUGOVI (milijardi)LANGF. DUŽNIČKI KAPITAL (milijardi)KRATK. POTR. (milijardi)LANGF. VEZA (milijardi)LATENTNI POREZI (milijardi)S. VEZA. (milijardi)LANGF. VEZA (milijardi)OBVEZE (milijardi)UKUPNI KAPITAL (milijardi)
1990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
00,010,140,100,340,160,120,080,080,080,060,190,260,751,640,851,671,451,640,860,210,270,210,220,590,320,200,190,150,221,731,930,930,87
0,030,040,050,060,140,210,320,370,540,450,360,370,440,540,900,931,391,501,401,381,321,251,221,311,181,281,471,551,611,831,531,781,972,23
05,0000000000000000000000000000000000
0,030,040,040,040,100,150,240,390,460,380,350,300,240,280,360,420,680,730,850,890,890,930,880,900,951,020,961,081,171,581,351,611,872,48
0,000,010,010,010,070,050,140,180,190,160,220,250,270,310,390,432,292,261,561,471,190,660,710,590,890,860,621,011,081,082,081,001,000,94
0,060,090,240,220,660,580,821,021,271,060,991,111,211,883,292,636,035,945,454,603,623,113,023,013,613,473,243,824,004,706,696,325,766,51
0,030,040,050,080,220,260,360,500,680,600,570,590,640,740,871,011,641,721,731,721,701,671,561,551,511,491,631,701,782,422,542,692,833,30
000000066,0034,0055,0099,00154,00210,00558,00529,00594,00596,00317,00000000000000918,00412,00407,00413,00
0000000000000000000000000000000000
00000,080,140,200,210,940,890,851,151,201,191,631,808,387,967,246,676,346,476,295,955,616,195,885,846,377,895,926,125,906,00
0000000,120,100,880,840,820,921,171,281,711,9414,0015,1012,4211,9410,199,765,975,695,906,476,687,007,9110,189,9511,9912,9214,39
0,010,010,010,030,040,140,090,030,100,130,100,060,030,060,140,230,230,160,290,250,290,280,310,370,410,510,670,690,935,394,764,704,654,52
0,040,050,060,110,330,540,770,902,632,522,442,873,243,824,885,5724,8525,2621,6920,5818,5118,1914,1313,5613,4214,6614,8615,2217,0025,8724,0825,9126,7128,62
0,100,140,300,320,991,111,591,923,893,573,433,974,455,708,178,2030,8831,2027,1425,1822,1321,2917,1516,5717,0218,1318,1019,0421,0030,5730,7832,2332,4735,14
1,001,001,001,002,002,002,002,004,004,004,004,004,008,008,008,0015,0015,0015,0015,0015,0015,0015,0016,0016,0016,0016,0016,0016,0016,0017,0017,0017,0017,00
0,020,020,140,130,310,390,440,430,511,211,211,231,251,231,631,6615,7915,7915,9416,0916,2316,3516,4316,5816,7016,8617,0117,1617,3517,5619,7319,9920,2920,65
0,030,070,110,180,450,420,570,680,380,751,121,031,391,792,793,41-0,17-0,69-2,73-3,76-4,82-4,38-8,45-8,57-8,69-8,93-8,58-8,39-6,95-2,25-2,38-1,39-0,750,82
01,000-1,001,00-6,00-13,00-76,00-72,00-123,00-130,00-97,00-125,00-99,00-88,00-103,00-17,00-29,00-53,00-43,00-129,00-138,00-33,00106,00144,0088,007,00-57,0034,00270,00206,00262,00268,0050,00
00000019,0017,001,007,0017,0025,00-2,0050,002,0026,0016,0016,0000000000-6,00-1,00000000
0,050,090,250,310,760,801,021,050,821,852,222,192,522,974,355,0015,6315,1013,1712,3011,3011,857,968,138,178,048,458,7310,4415,5917,5818,8719,8221,53
6,007,006,0011,0033,0043,0067,0099,00109,0092,0067,0054,0066,0078,00108,00105,00204,00139,00239,00212,00184,00203,00232,00246,00262,00209,00447,00530,00349,00542,00513,00794,00862,00942,00
0,010,010,010,010,050,060,150,160,250,290,350,420,640,600,901,121,121,211,171,161,191,201,181,261,261,201,251,281,531,711,762,241,992,52
0,010,010,010,010,080,120,030,090,240,080,140,130,130,170,370,091,301,651,821,650,740,400,350,310,931,021,832,041,121,201,390,980,930,94
0,020,000,020,030,090,060,240,451,030,600,260,230,090,550,730,16000000000000000000
00000000000000,000,500,000,010,260,000,000,500,000,000,000,400,000,061,802,251,420,010,260,020,53
0,040,030,040,060,260,280,480,791,621,060,820,830,921,392,611,482,633,253,233,022,611,811,771,822,852,433,595,655,264,873,684,273,804,93
0,020,020,010,010,03000,051,360,690,570,970,851,171,141,868,907,936,745,924,934,264,254,243,845,675,423,824,808,599,138,808,928,57
00,000,000,00000,060,060000,040,100,150,260,262,572,282,261,881,641,871,711,401,210,740,020,190,330,600,330,310,140,13
0000,010,000,050,050,070,090,110,100,110,110,120,140,311,492,631,732,061,652,012,552,572,672,972,342,371,882,642,312,222,031,97
0,020,020,010,020,030,050,110,171,450,790,671,131,061,441,542,4412,9512,8510,739,858,228,138,518,217,729,387,786,387,0111,8211,7711,3311,0910,67
0,050,050,050,080,290,340,590,973,071,851,491,961,982,844,153,9115,5816,1013,9712,8810,839,9410,2810,0310,5711,8111,3612,0312,2716,6915,4515,6114,9015,61
0,100,140,300,381,051,141,612,023,893,703,714,154,505,818,498,9131,2231,2027,1425,1822,1321,7818,2518,1618,7419,8519,8120,7622,7232,2833,0334,4834,7237,14
Detalji

Bilans

ⓘ

Razumevanje bilansa

Bilans kompanije Boston Scientific pruža detaljan finansijski pregled i prikazuje sredstva, obaveze i kapital u određenom trenutku. Analiza ovih komponenti je ključna za investitore koji žele da razumeju finansijsko zdravlje i stabilnost kompanije Boston Scientific.

Sredstva

Sredstva kompanije Boston Scientific predstavljaju sve što kompanija poseduje ili kontroliše i što ima novčanu vrednost. Ova se podeljena na obrtna i dugotrajna sredstva i pružaju uvid u likvidnost i dugoročne investicije kompanije.

Obaveze

Obaveze su dugovi koje će kompanija Boston Scientific morati da izmiri u budućnosti. Analiza odnosa obaveza prema sredstvima daje informacije o finansijskoj poluzi i riziku kojem je kompanija izložena.

Kapital

Kapital se odnosi na preostali interes u sredstvima kompanije Boston Scientific nakon odbijanja obaveza. Predstavlja potraživanje vlasnika na sredstva i prihode kompanije.

Analiza iz godine u godinu

Upoređivanje podataka iz bilansa iz godine u godinu omogućava investitorima da prepoznaju trendove, uzorke rasta i potencijalne finansijske rizike te da donose informisane odluke o investiranju.

Interpretacija podataka

Detaljna analiza sredstava, obaveza i kapitala može investitorima pružiti sveobuhvatan uvid u finansijsko stanje kompanije Boston Scientific i pomoći im u proceni investicija i oceni rizika.

 
NETO DOBIT (milijardi)AMORTIZACIJA (milijardi)ODLOŽENI POREZI (mil.)PROMENE OBRATNOG KAPITALA (mil.)STAVKE BEZ GOTOVINE (milijardi)PLAĆENE KAMATE (mil.)PLAĆENI POREZI (milijardi)NETO-CASHFLOW IZ POSLOVNE AKTIVNOSTI (milijardi)KAPITALNE INVESTICIJE (mil.)CASHFLOW IZ INVESTICIONE AKTIVNOSTI (mil.)CASHFLOW OD DRUGIH INVESTICIONIH AKTIVNOSTI (milijardi)PRIHODI I RASHODI OD KAMATA (mil.)NETO PROMENA DUGA (milijardi)NETO PROMENA KAPITALA (milijardi)CASHFLOW FINANSIJSKE AKTIVNOSTI (milijardi)CASHFLOW OD OSTALIH FINANSIJSKIH AKTIVNOSTI (mil.)UKUPNO ISPLAĆENI DIVIDENDI (mil.)NETO PROMENA U CASH FLOW-u (milijardi)SLOBODAN CASH FLOW (mil.)KOMPENZACIJA ZASNOVANA NA AKCIJAMA (mil.)
19891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0,010,020,040,060,080,14-0,020,170,11-0,260,370,37-0,050,370,471,060,63-3,58-0,50-2,04-1,03-1,070,44-4,07-0,12-0,12-0,240,350,101,674,70-0,081,040,701,59
0,000,000,000,000,030,040,040,070,090,130,180,180,230,160,200,280,310,730,920,860,830,820,720,680,690,730,770,820,840,891,011,121,091,141,20
0000-38,00-22,00-8,00-11,00-52,00-151,00-29,002,008,00142,00-31,0030,004,00-420,00-386,00-334,00-64,00-110,0046,00-166,00-223,00-397,00-532,00-305,00245,00-87,00-4.301,00-82,00-124,00-63,00-1,00
-1,00-7,00-15,00-19,0045,00-51,00-48,00-205,00-124,00-96,00212,00192,0025,00-27,00-41,0074,00-403,00358,0047,00-77,00922,00-1.362,00-244,00297,00214,00989,00326,00206,0067,00-2.162,00-284,0041,00-351,00-1.006,00-771,00
00000-0,000,060,130,060,680,04-0,010,280,090,190,360,364,760,972,940,312,200,184,640,660,170,470,240,290,130,870,680,410,980,72
6,005,003,002,003,004,006,0013,0019,0065,00117,0069,0059,0043,0052,0061,0087,00383,00543,00414,00364,00328,00277,00255,00329,00221,00283,00233,00235,00262,00449,00359,00338,00450,00259,00
0,000,010,020,040,080,090,080,090,090,110,090,050,110,040,030,070,350,200,480,420,05-0,290,140,100,070,070,080,090,041,040,240,210,300,660,51
0,010,020,030,040,110,100,030,140,080,290,780,740,490,740,791,800,901,850,931,220,840,331,011,281,111,270,691,181,430,311,841,511,871,532,50
-7,00-3,00-7,00-10,00-106,00-99,00-199,00-228,00-267,00-177,00-83,00-126,00-205,00-314,00-513,00-546,00-549,00-439,00-486,00-418,00-362,00-278,00-315,00-248,00-289,00-285,00-513,00-508,00-450,00-488,00-610,00-522,00-554,00-588,00-711,00
-7,00-5,00-10,00-50,00-137,00-50,00-182,00-401,00-251,00-2.225,00-185,00-107,00-800,00-485,00-871,00-1.622,00-551,00-9.312,00-474,00324,00-793,00-480,00769,00-579,00-475,00-745,00-2.186,00-887,00-1.010,00-1.921,00-5.041,00-411,00-1.597,00-2.011,00-2.574,00
0-0,00-0,00-0,04-0,030,050,02-0,170,02-2,05-0,100,02-0,60-0,17-0,36-1,08-0,00-8,870,010,74-0,43-0,201,08-0,33-0,19-0,46-1,67-0,38-0,56-1,43-4,430,11-1,04-1,42-1,86
00000000000000000000000000000000000
0-0,01-0,01-0,010,030,04-0,040,180,251,88-1,12-0,450,40-0,280,790,58-0,316,89-0,75-1,43-0,85-0,53-1,25-0,02-0,0101,39-0,190,121,412,79-1,000-0,17-0,00
0000,12-0,060,030,050,01-0,090,070,53-0,190,040,11-0,31-0,14-0,641,550,070,070,030,03-0,47-0,58-0,43-0,070,110,110,090,100,121,530,110,140,18
0-0,01-0,010,10-0,020,080,010,200,161,94-0,59-0,640,44-0,180,490,44-0,958,44-0,68-1,35-0,82-0,50-1,72-0,76-0,62-0,151,28-0,210,111,432,970,29-0,10-0,550,01
0001,001,000000-5,00-1,002,0001,004,00-3,00-1,006,002,004,00000-166,00-188,00-85,00-223,00-127,00-98,00-74,0056,00-206,00-150,00-464,00-145,00
000-20,00000000000000000000000000000-28,00-55,00-55,00-28,00
000,010,09-0,050,12-0,14-0,06-0,010,01-0,01-0,010,130,080,410,63-0,610,98-0,220,19-0,78-0,650,05-0,060,010,37-0,220,090,53-0,19-0,221,390,17-1,04-0,07
-0,2015,6022,3032,103,40-3,00-167,40-86,80-186,50116,00693,00613,00285,00422,00274,001.258,00354,001.406,00448,00798,00473,0047,00693,001.032,00821,00984,00178,00674,00976,00-179,001.226,00986,001.317,00938,001.792,00
00000000000000000000000000000000000

Boston Scientific Акција Маргине

Boston Scientific анализа маржи приказује бруто маржу, ЕБИТ маржу, као и маржу добити компаније Boston Scientific. ЕБИТ маржа (ЕБИТ/продаја) указује колики проценат од продате робе остаје као оперативни добитак. Маржа добити показује колики проценат продате робе компаније Boston Scientific остаје.

  • 3 godine

  • 5 godina

  • 10 godina

  • 25 godina

  • Maks

Bruto marža
EBIT marža
Profitna marža
Detalji

Margine

ⓘ

Razumevanje bruto marže

Bruto marža, izražena u procentima, pokazuje bruto dobit od prodaje Boston Scientific. Viši procenat bruto marže znači da Boston Scientific zadržava više prihoda nakon što su uzeti u obzir troškovi prodatih roba. Investitori koriste ovaj pokazatelj da ocene finansijsko zdravlje i operativnu efikasnost, i da je uporede sa konkurentima i prosečnim vrednostima u industriji.

Analiza marže EBIT

Marža EBIT predstavlja profit Boston Scientific pre kamata i poreza. Analiza marže EBIT kroz različite godine pruža uvide u operativnu profitabilnost i efikasnost, bez efekata finansijskog leveraginga i poreske strukture. Rastuća marža EBIT tokom godina signalizira poboljšanu operativnu izvedbu.

Uvidi u maržu obrta

Marža obrta pokazuje ukupan promet koji Boston Scientific ostvari. Upoređivanjem marže obrta iz godine u godinu, investitori mogu da procene rast i širenje tržišta Boston Scientific. Važno je uporediti maržu obrta sa bruto i EBIT maržom, kako bi se bolje razumele strukture troškova i profita.

Tumačenje očekivanja

Očekivane vrednosti za bruto, EBIT i maržu obrta daju budući finansijski izgled Boston Scientific. Investitori bi trebali da uporede ova očekivanja sa istorijskim podacima kako bi razumeli potencijalni rast i faktore rizika. Presudno je uzeti u obzir pretpostavke i metode koje su korišćene za prognozu ovih očekivanih vrednosti kako bi se donosile informisane investicione odluke.

Analiza poređenja

Poređenje bruto, EBIT i marži obrta, godišnje i kroz više godina, omogućuje investitorima da izvrše sveobuhvatnu analizu finansijskog zdravlja i perspektive rasta Boston Scientific. Procena trendova i obrazaca u tim maržama pomaže u identifikovanju snaga, slabosti i potencijalnih investicionih prilika.

Boston Scientific Istorija margine

Boston Scientific Bruto maržaBoston Scientific Profitna maržaBoston Scientific EBIT maržaBoston Scientific Profitna marža
2029e69,65 %0 %0 %
2028e69,65 %29,12 %24,23 %
2027e69,65 %28,57 %23,46 %
2026e69,65 %27,66 %22,79 %
2025e69,65 %27,24 %22,23 %
2024e69,65 %26,71 %21,72 %
202369,65 %17,05 %11,03 %
202269,00 %16,33 %5,06 %
202169,04 %17,77 %8,29 %
202065,24 %9,10 %-1,16 %
201970,67 %16,96 %43,78 %
201871,13 %17,70 %17,01 %
201771,09 %18,45 %1,15 %
201670,56 %15,98 %4,14 %
201570,42 %12,36 %-3,20 %
201468,88 %14,02 %-1,61 %
201367,60 %12,64 %-1,69 %
201265,60 %13,26 %-56,12 %
201163,25 %13,33 %5,79 %
201064,34 %12,72 %-13,64 %
200966,21 %15,32 %-12,52 %
200866,81 %15,79 %-25,29 %
200769,56 %14,28 %-5,92 %
200668,83 %15,68 %-45,74 %
200574,33 %32,21 %10,00 %
200473,56 %30,48 %18,88 %

Boston Scientific акција промет, EBIT, добит по акцији

Boston Scientific-промет по акцији отуда показује колико промета Boston Scientific у једном периоду припада свакој акцији. EBIT по акцији показује колико оперативног профита припада свакој акцији. Добит по акцији указује колико профита припада свакој акцији.

  • 3 godine

  • 5 godina

  • 10 godina

  • 25 godina

  • Maks

Prihod po akciji
EBIT po akciji
Dobit po akciji
Detalji

Promet, EBIT i Zarada po deonici

ⓘ

Promet po deonici

Promet po deonici predstavlja ukupan promet koji Boston Scientific ostvaruje, podeljen brojem izdatih deonica. To je ključna metrika, jer odražava sposobnost kompanije da generiše promet i pokazuje potencijal za rast i širenje. Godišnja poređenja prometa po deonici omogućuju investitorima da analiziraju postojanost prihoda kompanije i predviđaju buduće trendove.

EBIT po deonici

EBIT po deonici označava dobit Boston Scientific pre kamata i poreza, i pruža uvid u operativnu profitabilnost, ne uzimajući u obzir efekte kapitalne strukture i poreske stope. Može se uporediti s prometom po deonici kako bi se ocenila efikasnost pretvaranja prodaje u profit. Konstantan porast EBIT-a po deonici tokom godina naglašava operativnu efikasnost i profitabilnost.

Prihod po deonici

Prihod po deonici ili Zarada po deonici (EPS) pokazuje deo dobiti Boston Scientific koji se dodeljuje svakoj deonici osnovnog kapitala. To je ključno za ocenu profitabilnosti i finansijskog zdravlja. Poređenjem s prometom i EBIT-om po deonici, investitori mogu videti koliko efikasno kompanija pretvara promet i operativni profit u neto prihod.

Očekivane vrednosti

Očekivane vrednosti su prognoze za promet, EBIT i prihod po deonici za naredne godine. Ove prognoze, koje se baziraju na istorijskim podacima i tržišnim analizama, pomažu investitorima da strategizuju svoje investicije, ocene buduće poslovanje Boston Scientific i procene buduće cene deonica. Međutim, ključno je uzeti u obzir tržišne volatilnosti i neizvesnosti koje mogu uticati na ove prognoze.

Boston Scientific Promet, dobit i EBIT po akciji - istorija

DatumBoston Scientific Prihod po akcijiBoston Scientific EBIT po akcijiBoston Scientific Dobit po akciji
2029e17,10 undefined0 undefined0 undefined
2028e15,51 undefined0 undefined3,76 undefined
2027e14,27 undefined0 undefined3,35 undefined
2026e13,57 undefined0 undefined3,09 undefined
2025e12,35 undefined0 undefined2,75 undefined
2024e11,16 undefined0 undefined2,42 undefined
20239,73 undefined1,66 undefined1,07 undefined
20228,81 undefined1,44 undefined0,45 undefined
20218,29 undefined1,47 undefined0,69 undefined
20207,00 undefined0,64 undefined-0,08 undefined
20197,61 undefined1,29 undefined3,33 undefined
20187,01 undefined1,24 undefined1,19 undefined
20176,50 undefined1,20 undefined0,07 undefined
20166,09 undefined0,97 undefined0,25 undefined
20155,58 undefined0,69 undefined-0,18 undefined
20145,57 undefined0,78 undefined-0,09 undefined
20135,33 undefined0,67 undefined-0,09 undefined
20125,15 undefined0,68 undefined-2,89 undefined
20115,02 undefined0,67 undefined0,29 undefined
20105,14 undefined0,65 undefined-0,70 undefined
20095,43 undefined0,83 undefined-0,68 undefined
20085,37 undefined0,85 undefined-1,36 undefined
20075,62 undefined0,80 undefined-0,33 undefined
20066,14 undefined0,96 undefined-2,81 undefined
20057,50 undefined2,42 undefined0,75 undefined
20046,55 undefined2,00 undefined1,24 undefined

Boston Scientific Akcija i analiza akcija

Boston Scientific Corp. is a global medical technology company specializing in the development and manufacturing of innovative solutions for medical challenges and needs. The company was founded in 1979 and has since been dedicated to meeting the individual needs of patients and medical professionals with innovative products. The history of Boston Scientific began in the 1960s when French engineer Jean-Marc Simon started developing pacemakers at the University of Minnesota. In 1969, Medtronic acquired Simon's pacemaker development, leading to the founding of Boston Scientific. From the beginning, the company focused on the production of cardiovascular implants, including pacemakers, implanted defibrillators, and stents. In the following years, the company achieved continued growth through acquisitions of competitors and advancements in research and development, particularly in the field of minimally invasive procedures. Today, Boston Scientific is a globally leading provider of innovative medical devices and solutions used in various areas of healthcare. Boston Scientific's business model is based on meeting the needs of patients, medical professionals, and healthcare policymakers in order to improve healthcare. The company works closely with doctors, hospitals, nursing facilities, and research institutions to continuously develop innovative solutions for various diseases and conditions. Boston Scientific has five business segments: Cardiovascular Systems, Interventional Oncology and Neuromodulation, Urology and Women's Health, Medical Oncology, and Endoscopy. The Cardiovascular Systems segment includes products and solutions for cardiovascular surgery, including pacemakers, implanted defibrillators, and catheters. The company is also involved in endovascular surgery, offering innovative stent and catheter systems for the treatment of aneurysms and arterial occlusive disease. The Interventional Oncology and Neuromodulation segment includes solutions for the minimally invasive treatment of cancer and chronic pain through catheter and implant systems. For example, Boston Scientific offers intensity-controlled radiofrequency ablation and neuromodulation procedures. The Urology and Women's Health segment includes products for the treatment and diagnosis of urogenital system disorders, including incontinence, urinary incontinence, and genital diseases. Boston Scientific offers innovative solutions for women, such as the treatment of urinary incontinence or the removal of uterine fibroids. The Medical Oncology segment includes products for the diagnosis and treatment of cancer, including in vitro diagnostics and novel treatments such as chemotherapy delivery technology. The Endoscopy segment includes endoscopic solutions, including the diagnosis and therapy of digestive tract, chest, and lung disorders. Boston Scientific's product portfolio is diverse and includes numerous innovative medical devices and systems designed to meet the needs of patients and medical professionals. Some of the notable products of the company include: - The Implantable Cardioverter-Defibrillator (ICD) is an innovative device that can treat heart rhythm disorders through the use of a remote control. - Drug-Eluting Stents are stents that deliver medication directly at the site of narrowing, promoting blood flow and helping to keep the artery open. - The Synergy is a top-of-the-line stent that has both a lower mortality rate and a higher success rate than conventional stents. - The Venus-EP Steerable Sheath is an advanced catheter that allows physicians unique navigation within the heart chambers. - The Precision is a catheter that sends impulses to the heart for the diagnosis and treatment of atrial fibrillation. - The Transcend is a pacemaker that combines traditional pacemaker function with a sensor that actively supports the patient during physical activity. - The Symphion is an innovative system for laparoscopic surgery that enables minimally invasive surgical procedures in women. In conclusion, Boston Scientific Corp. is a globally leading provider of innovative medical devices and solutions that run like a common thread through its various business segments. With a significant focus on research and development, the company offers a wide range of products to ensure that patients worldwide have access to innovative medical care. Through pioneering innovations, the development of new technologies, and collaboration with medical professionals, Boston Scientific will continue to defend its position as a leading provider of medical solutions worldwide. Boston Scientific je jedna od najpopularnijih kompanija na Eulerpool.com.

Boston Scientific Оцена према Fair Value

Detalji

Fair Value

ⓘ

Razumevanje Fair Value

Fair Value jedne akcije pruža uvid u to da li je akcija trenutno potcenjena ili precenjena. On se izračunava na osnovu prihoda, dobiti ili dividende i nudi sveobuhvatan pogled na unutrašnju vrednost akcije.

Fair Value zasnovan na dobitku

Izračunava se množenjem dobiti po akciji sa prosečnim P/E odnosom izabranih prethodnih godina za izračunavanje srednje vrednosti (izgladnjivanja). Ako je Fair Value veći od trenutne tržišne cene, to ukazuje na to da je akcija potcenjena.

Primer 2022

Fair Value dobiti 2022 = Dobit po akciji 2022 / Prosečni P/E 2019 - 2021 (izgladnjivanje 3 godine)

Fair Value zasnovan na prihodu

Izvodi se množenjem prihoda po akciji sa prosečnim cena/prihod odnosom izabranih prethodnih godina za izračunavanje srednje vrednosti (izgladnjivanje). Potcenjena akcija se identifikuje ako Fair Value premašuje trenutnu tržišnu cenu.

Primer 2022

Fair Value prihoda 2022 = Prihod po akciji 2022 / Prosečni P/S 2019 - 2021 (izgladnjivanje 3 godine)

Fair Value zasnovan na dividendi

Ova vrednost se određuje deljenjem dividende po akciji sa prosečnim prinosom na dividende izabranih prethodnih godina za izračunavanje srednje vrednosti (izgladnjivanje). Viši Fair Value od tržišne cene signalizira potcenjenost akcije.

Primer 2022

Fair Value dividende 2022 = Dividenda po akciji 2022 * Prosečni prinos na dividende 2019 - 2021 (izgladnjivanje 3 godine)

Očekivanja i prognoze

Buduća očekivanja pružaju potencijalne putanje za cene akcija i pomažu investitorima u donošenju odluka. Očekivane vrednosti su prognozirane cifre Fair Value, uzimajući u obzir trendove rasta ili opadanja dobiti, prihoda ili dividendi.

Uporedna analiza

Upoređivanje Fair Value, na osnovu dobiti, prihoda i dividendi, pruža celovit uvid u finansijsko zdravlje akcije. Praćenje godišnjih i medjugodišnjih varijacija doprinosi razumevanju konzistentnosti i pouzdanosti performansi akcija.

Boston Scientific Ocena na osnovu istorijskog KGV, EBIT i KUV

Boston Scientific Broj akcija

Broj deonica kompanije Boston Scientific u godini 2023 — Ovo pokazuje na koliko deonica se 1,464 milijardi deli. Pošto su akcionari vlasnici preduzeća, svaka deonica predstavlja mali deo vlasništva nad preduzećem.

  • 3 godine

  • 5 godina

  • 10 godina

  • 25 godina

  • Maks

Broj akcija
Detalji

Promet, EBIT i Zarada po deonici

ⓘ

Promet po deonici

Promet po deonici predstavlja ukupan promet koji Boston Scientific ostvaruje, podeljen brojem izdatih deonica. To je ključna metrika, jer odražava sposobnost kompanije da generiše promet i pokazuje potencijal za rast i širenje. Godišnja poređenja prometa po deonici omogućuju investitorima da analiziraju postojanost prihoda kompanije i predviđaju buduće trendove.

EBIT po deonici

EBIT po deonici označava dobit Boston Scientific pre kamata i poreza, i pruža uvid u operativnu profitabilnost, ne uzimajući u obzir efekte kapitalne strukture i poreske stope. Može se uporediti s prometom po deonici kako bi se ocenila efikasnost pretvaranja prodaje u profit. Konstantan porast EBIT-a po deonici tokom godina naglašava operativnu efikasnost i profitabilnost.

Prihod po deonici

Prihod po deonici ili Zarada po deonici (EPS) pokazuje deo dobiti Boston Scientific koji se dodeljuje svakoj deonici osnovnog kapitala. To je ključno za ocenu profitabilnosti i finansijskog zdravlja. Poređenjem s prometom i EBIT-om po deonici, investitori mogu videti koliko efikasno kompanija pretvara promet i operativni profit u neto prihod.

Očekivane vrednosti

Očekivane vrednosti su prognoze za promet, EBIT i prihod po deonici za naredne godine. Ove prognoze, koje se baziraju na istorijskim podacima i tržišnim analizama, pomažu investitorima da strategizuju svoje investicije, ocene buduće poslovanje Boston Scientific i procene buduće cene deonica. Međutim, ključno je uzeti u obzir tržišne volatilnosti i neizvesnosti koje mogu uticati na ove prognoze.

Boston Scientific Deonice podataka

U istoriji Boston Scientific još uvek nije bilo deoba akcija.
Trenutno, nažalost, nema dostupnih ciljanih cena i prognoza za Boston Scientific.

Boston Scientific Iznenađenja u zaradi

DatumProcena EPSaEPS-ActualKvartal izveštaja
30. 6. 2024.0,59 0,62  (5,78 %)2024 Q2
31. 3. 2024.0,52 0,56  (8,11 %)2024 Q1
31. 12. 2023.0,52 0,55  (6,30 %)2023 Q4
30. 9. 2023.0,48 0,50  (3,82 %)2023 Q3
30. 6. 2023.0,49 0,53  (7,20 %)2023 Q2
31. 3. 2023.0,44 0,47  (6,55 %)2023 Q1
31. 12. 2022.0,48 0,49  (2,42 %)2022 Q4
30. 9. 2022.0,45 0,43  (-3,48 %)2022 Q3
30. 6. 2022.0,43 0,44  (2,66 %)2022 Q2
31. 3. 2022.0,39 0,39  (0,15 %)2022 Q1
1
2
3
4
5
...
11

Eulerpool ESG ocena za akciju Boston Scientific

Eulerpool World ESG Rating (EESG©)

88/ 100

🌱 Environment

91

👫 Social

99

🏛️ Governance

75

Životna sredina (Environment)

Direktne emisije
35.596
Indirektne emisije iz kupljene energije
13.121
Indirektne emisije unutar lanca vrednosti
—
CO₂ emisije
48.717
Strategija redukcije CO₂
✅
Ugalj energija
❌
Atomska energija
❌
Eksperimenti na životinjama
✅
Pelz & Leder
❌
Pesticidi
❌
Palmino ulje
❌
Tabak
❌
Gentechnika
❌
Koncept klime
—
Održivo šumarstvo
—
Pravila o reciklaži
✅
Ekološka ambalaža
✅
Opasne materije
✅
Potrošnja i efikasnost goriva
✅
Potrošnja i efikasnost vode
✅

Društveno (Social)

Udeo žena zaposlenih49
Udeo žena u menadžmentu—
Udeo azijskih zaposlenih12,8
Udeo azijskog menadžmenta—
Udeo hispansko/latinskih zaposlenih11,9
Udeo hispano/latino menadžmenta—
Udeo crnačkih zaposlenih9,2
Udeo crnačkog menadžmenta—
Udeo belih zaposlenih63,8
Udeo belačkog menadžmenta—
Sadržaji za odrasle❌
Alkohol❌
Odbrana—
oružje
❌
Kockanje❌
Ugovori o vojsci❌
Koncept ljudskih prava✅
Koncept zaštite podataka—
Zaštita na radu i zdravlje✅
Katolički✅

Upravljanje preduzećem (Governance)

Izveštaj o održivosti✅
Angažovanje zainteresovanih strana✅
Politika povlačenja❌
Antimonopolsko pravo❌

Renomirani Eulerpool ESG rejting je strogo autorsko zaštićena intelektualna svojina Eulerpool Research Systems. Svaka neovlašćena upotreba, imitacija ili kršenje će biti odlučno gonjena i može dovesti do značajnih pravnih posledica. Za licence, saradnju ili prava korišćenja molimo Vas da se direktno obratite preko našeg Formular za kontakt na nas.

Boston Scientific Akcija Struktura vlasništva

%
Ime
Акције
Promena
Datum
8,65 % Fidelity Management & Research Company LLC127.221.21811.483.14431. 12. 2023.
8,49 % The Vanguard Group, Inc.124.818.7661.653.13231. 12. 2023.
4,62 % BlackRock Institutional Trust Company, N.A.67.855.849-542.88831. 12. 2023.
4,24 % State Street Global Advisors (US)62.334.606388.75031. 12. 2023.
3,71 % MFS Investment Management54.485.140-5.235.17631. 12. 2023.
2,58 % PRIMECAP Management Company37.905.659550.49031. 12. 2023.
2,48 % Wellington Management Company, LLP36.441.127-5.635.40231. 12. 2023.
1,87 % Geode Capital Management, L.L.C.27.556.215559.89831. 12. 2023.
1,52 % The Bollard Group, LLC22.391.511-953.21531. 12. 2023.
1,32 % Janus Henderson Investors19.450.617-1.107.04131. 12. 2023.
1
2
3
4
5
...
10

Boston Scientific Upravni i Nadzorni odbor

Mr. Michael Mahoney58
Boston Scientific Chairman of the Board, President, Chief Executive Officer (od 2011)
Naknada: 16,94 mil.
Mr. Daniel Brennan57
Boston Scientific Chief Financial Officer, Executive Vice President
Naknada: 5,25 mil.
Mr. Joseph Fitzgerald59
Boston Scientific Executive Vice President, Group President - Cardiology
Naknada: 4,76 mil.
Mr. Arthur Butcher52
Boston Scientific Executive Vice President, Group President, MedSurg and Asia Pacific
Naknada: 4,17 mil.
Mr. Jeffrey Mirviss57
Boston Scientific Executive Vice President and President - Peripheral Interventions
Naknada: 3,56 mil.
1
2
3
4
...
5

Boston Scientific lanac snabdevanja

ImeOdnosDvonedeljna korelacijaKorelacija za jedan mesecTrojmešečna korelacijaŠestomesečna korelacijaJednogodišnja korelacijaDvogodišnja korelacija
Zinc Media Group Akcija
Zinc Media Group
DobavljačKlijent-0,02-0,40-0,070,250,43
Lisi S.A. Akcija
Lisi S.A.
DobavljačKlijent-----0,22
Japan Lifeline Co., Ltd. Akcija
Japan Lifeline Co., Ltd.
DobavljačKlijent-----0,10
Nolato AB (publ) Akcija
Nolato AB (publ)
DobavljačKlijent----0,59-0,81-0,37
PTC Akcija
PTC
DobavljačKlijent0,760,39-0,47-0,370,510,36
SurModics Akcija
SurModics
DobavljačKlijent0,680,440,590,070,810,60
Integer Holdings Akcija
Integer Holdings
DobavljačKlijent0,670,390,770,540,740,64
Johnson & Johnson Akcija
Johnson & Johnson
DobavljačKlijent0,620,100,380,590,790,49
Tufin Software Technologies Ltd. Akcija
Tufin Software Technologies Ltd.
DobavljačKlijent0,530,420,550,28-0,130,37
Asahi Intecc Akcija
Asahi Intecc
DobavljačKlijent0,480,330,650,20-0,67-0,10
1
2
3
4

Česta pitanja o Boston Scientific akciji

What values and corporate philosophy does Boston Scientific represent?

Boston Scientific Corp represents values of innovation, collaboration, and patient-centricity. With a strong corporate philosophy focused on improving patients' lives, the company is committed to developing and delivering innovative medical solutions. Boston Scientific Corp's dedication to collaboration extends to its partnerships with healthcare professionals and institutions, helping to address unmet needs and improve patient outcomes. By prioritizing patient-centric care, the company ensures that its products and services are designed to provide effective and meaningful treatments. Boston Scientific Corp's continued commitment to innovation and collaboration underscores its mission to transform lives through medical advancements in a rapidly evolving healthcare landscape.

In which countries and regions is Boston Scientific primarily present?

Boston Scientific Corp is primarily present in several countries and regions worldwide. The company has a strong global presence, with significant operations in the United States, Europe, Asia-Pacific, Latin America, and the Middle East. Its diverse market reach spans across more than 130 countries, enabling Boston Scientific Corp to provide innovative medical solutions and technologies to a vast range of patients and healthcare professionals worldwide.

What significant milestones has the company Boston Scientific achieved?

Boston Scientific Corp has achieved significant milestones throughout its history. Some notable achievements include the development of the Taxus Express, a groundbreaking drug-eluting stent that revolutionized the treatment of coronary artery disease. Additionally, the acquisition of Guidant Corporation strengthened Boston Scientific's position in the field of cardiac rhythm management. The company's innovative products, such as the Watchman Left Atrial Appendage Closure device, have provided improved treatment options for patients with atrial fibrillation. Boston Scientific Corp continues to innovate and make advancements in medical technologies, helping to improve patient outcomes worldwide.

What is the history and background of the company Boston Scientific?

Boston Scientific Corp is a renowned medical technology company based in Marlborough, Massachusetts. Established in 1979, it has become a global leader in the development, manufacturing, and marketing of innovative medical devices. With a focus on advancing patient care, Boston Scientific Corp offers a wide range of products for various medical specialties, including interventional cardiology, urology, endoscopy, and neuromodulation. The company's history showcases its commitment to medical breakthroughs and improving the lives of patients worldwide. Boston Scientific Corp's dedication to cutting-edge technology and strategic acquisitions has allowed it to maintain a prominent position in the healthcare industry.

Who are the main competitors of Boston Scientific in the market?

The main competitors of Boston Scientific Corp in the market include Medtronic, Johnson & Johnson, Abbott Laboratories, and Edwards Lifesciences.

In which industries is Boston Scientific primarily active?

Boston Scientific Corp is primarily active in the medical equipment and supplies industry.

What is the business model of Boston Scientific?

Boston Scientific Corp is a global medical technology company. Its business model revolves around developing innovative medical solutions that enhance patient care and healthcare outcomes. Boston Scientific Corp manufactures and markets a broad range of medical devices used in various specialties, such as cardiology, urology, endoscopy, and neuromodulation. The company's commitment to research and development enables it to introduce advanced technologies and therapies that address unmet clinical needs. Boston Scientific Corp also focuses on collaborations and partnerships to expand its product portfolio, improve access to healthcare, and provide high-quality medical devices to patients worldwide.

Koji P/E odnos ima Boston Scientific 2024?

P/E odnos Boston Scientific iznosi 30,30.

Koji je KUV za Boston Scientific 2024?

KUV kompanije Boston Scientific iznosi 6,58.

Koji AlleAktien kvalitetni skor ima Boston Scientific?

AlleAktien kvalitativni skor za Boston Scientific je 6/10.

Koliki je prihod od Boston Scientific 2024?

očekivana Boston Scientific promet je 16,40 milijardi USD.

Koliki je profit kompanije Boston Scientific 2024?

Dobit očekivana Boston Scientific je 3,56 milijardi USD.

Шта ради Boston Scientific?

The Boston Scientific Corporation is a medical technology company that specializes in the manufacturing and development of medical devices. The company was founded in Massachusetts in 1979 and operates globally today. Its business model includes various divisions that focus on different medical specialties. The Cardiac Rhythm Management division of Boston Scientific is involved in the manufacturing of devices for the treatment of heart rhythm disorders. This includes products such as implantable defibrillators, pacemakers, and accessories. The products in this division are of high quality and have an excellent track record in treating patients with severe heart problems. The Interventional Cardiology division of Boston Scientific specializes in the manufacturing of products used in the treatment of heart diseases. This includes balloon catheters, stents, and catheter ablation systems. These products are typically minimally invasive and allow for a quick restoration of normal heart rhythm in patients. The Interventional Radiology division of Boston Scientific is focused on the manufacturing of products for the diagnosis and treatment of vascular diseases. The company produces catheters, stents, and embolization accessories, among other things. Additionally, Boston Scientific is also specialized in the development of products for the treatment of chronic pain. The products in this division include implantable pain therapy systems, neurostimulators, and accessories. These devices can alleviate patients' pain and improve their quality of life. The company is also specialized in the field of urology, including products for the treatment of conditions such as urinary incontinence and benign prostatic hyperplasia. Boston Scientific produces mesh implants and devices aimed at improving bladder control. Furthermore, the company has a division dedicated to gastrointestinal diseases, including products for the treatment of conditions like colorectal cancer and gastrointestinal bleeding. The portfolio includes endoscopes, balloon catheters, and other devices for the treatment of digestive tract disorders. Boston Scientific is committed to providing its customers with the best products. Product development is strongly focused on meeting the needs of patients and doctors. By continually developing new products, the company can expand its market position and maintain its leading position in the medical technology industry.

Kolika je Boston Scientific dividenda?

Boston Scientific isplaćuje dividendu od 0 USD raspoređenu preko isplata u toku godine.

Koliko često Boston Scientific isplaćuje dividendu?

Dividenda za Boston Scientific trenutno ne može biti izračunata ili kompanija ne isplaćuje dividendu.

Šta je Boston Scientific ISIN?

ISIN od Boston Scientific je US1011371077.

Šta je Boston Scientific WKN?

WKN od Boston Scientific je 884113.

Koji je Boston Scientific berzanski simbol?

Oznaka za praćenje akcija kompanije Boston Scientific je BSX.

Kolika je dividenda koju isplaćuje Boston Scientific?

U poslednjih 12 meseci, Boston Scientific je isplatio dividendu u iznosu od . To odgovara dividendnom prinosu od oko . Za narednih 12 meseci, Boston Scientific će verovatno isplatiti dividendu od 0 USD.

Kolika je dividendna prinosa za Boston Scientific?

Dividendski prinos od Boston Scientific trenutno iznosi .

Kada Boston Scientific isplaćuje dividendu?

Boston Scientific isplaćuje dividende na kvartalnom nivou. One se isplaćuju u mesecima .

Koliko je sigurna dividenda od Boston Scientific?

Boston Scientific je isplaćivao dividendu svake godine u poslednjih 0 godina.

Kolika je dividenda kompanije Boston Scientific?

Za narednih 12 meseci očekuju se dividende u iznosu od 0 USD. To odgovara dividendnom prinosu od 0 %.

U kom sektoru se nalazi Boston Scientific?

Boston Scientific se svrstava u sektor 'Zdravlje'.

Wann musste ich die Aktien von Boston Scientific kaufen, um die vorherige Dividende zu erhalten?

Da biste primili poslednju dividendu od Boston Scientific od 7. 8. 2024. u iznosu od 0 USD, morali ste da imate akciju u depou pre Ex-dana 7. 8. 2024..

Kada je Boston Scientific poslednji put isplatio dividendu?

Isplata poslednje dividende izvršena je 7. 8. 2024..

Kolika je bila dividenda od Boston Scientific u godini 2023?

U godini 2023 kompanija Boston Scientific je isplatila 0 USD kao dividende.

U kojoj valuti Boston Scientific isplaćuje dividendu?

Dividende od Boston Scientific se isplaćuju u USD.

Ostali pokazatelji i analize od Boston Scientific u dubinskoj analizi

Naša analiza akcija za akciju Boston Scientific Promet uključuje važne finansijske pokazatelje kao što su prihod, profit, P/E odnos, P/S odnos, EBIT, kao i informacije o dividendama. Takođe, razmatramo aspekte poput akcija, tržišne kapitalizacije, dugova, kapitala i obaveza kompanije Boston Scientific Promet. Ako tražite detaljnije informacije o ovim temama, na našim podstranicama vam nudimo opsežne analize: